CPRX — Catalyst Pharmaceuticals, Inc. stock price, charts and financials

QT77Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
31.49
+0.00%
CPRXQT77Catalyst Pharmaceuticals, Inc.·NASDAQ
31.49+0.00%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Jul 24, 202615-12G15-12G
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 17, 20264Statement of changes in beneficial ownership
Jul 16, 2026EFFECTNotice of effectiveness
Jul 16, 2026S-8 POSS-8 POS
Jul 16, 2026S-8 POSS-8 POS
Jul 16, 2026POS AMPost-effective amendment
Jul 16, 20268-KCurrent report
Jul 16, 2026S-8 POSS-8 POS
Jul 16, 2026POS AMPost-effective amendment
Jul 16, 2026S-8 POSS-8 POS
Jul 16, 2026S-8 POSS-8 POS
Jul 16, 2026S-8 POSS-8 POS